160 related articles for article (PubMed ID: 3179439)
1. Plasminogen interactions with platelets in plasma.
Adelman B; Rizk A; Hanners E
Blood; 1988 Nov; 72(5):1530-5. PubMed ID: 3179439
[TBL] [Abstract][Full Text] [Related]
2. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
3. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
[TBL] [Abstract][Full Text] [Related]
4. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
5. Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release.
Mousa SA; Bozarth J; Forsythe M; Tsao P; Pease L; Reilly TM
Life Sci; 1994; 54(16):1155-62. PubMed ID: 8152339
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP.
Adelman B; Carlson P; Powers P
Blood; 1987 Nov; 70(5):1362-6. PubMed ID: 2822171
[TBL] [Abstract][Full Text] [Related]
7. Endogenous platelet fibrinogen surface expression on activated platelets.
Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
[TBL] [Abstract][Full Text] [Related]
8. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
9. The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering.
Isenberg WM; McEver RP; Phillips DR; Shuman MA; Bainton DF
J Cell Biol; 1987 Jun; 104(6):1655-63. PubMed ID: 3584243
[TBL] [Abstract][Full Text] [Related]
10. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
Gartner TK; Bennett JS
J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
[TBL] [Abstract][Full Text] [Related]
11. Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex.
Bennett JS; Shattil SJ; Power JW; Gartner TK
J Biol Chem; 1988 Sep; 263(26):12948-53. PubMed ID: 3417645
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
13. Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa.
Ando B; Wiedmer T; Hamilton KK; Sims PJ
J Biol Chem; 1988 Aug; 263(24):11907-14. PubMed ID: 3261296
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
15. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
16. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation.
Mohri H; Ohkubo T
Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797
[TBL] [Abstract][Full Text] [Related]
17. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
Barre DE
Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
Williams S; Gralnick H
Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
[TBL] [Abstract][Full Text] [Related]
19. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
[TBL] [Abstract][Full Text] [Related]
20. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]